Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar scootertrader (70.74) Submitted: 10/18/2011 3:53:51 PM : Outperform Start Price: $40.85 GILD Score: +15.66

This stock looks to really take off vs. other biotechs.

Report this Post Reply

Featured Broker Partners


Advertisement